Evidence map›Paper›PMID 35463907›Full record

ArticleFrontiers in pediatrics2022

Chemotherapy Combined With Surgery in a Case With Metanephric Adenoma.

Shaohua Hu, Zhenli Zhao, Zhisheng Wan, Weizhen Bu, Songqiang Chen, Yiqun Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shaohua HuDepartment of Urology, Hainan Women and Children's Medical Center, Haikou, China.
Zhenli ZhaoDepartment of Urology, Hainan Women and Children's Medical Center, Haikou, China.
Zhisheng WanDepartment of Urology, Hainan Women and Children's Medical Center, Haikou, China.
Weizhen BuDepartment of Urology, Hainan Women and Children's Medical Center, Haikou, China.
Songqiang ChenDepartment of Urology, Hainan Women and Children's Medical Center, Haikou, China.
Yiqun LuDepartment of Urology, Children's Hospital of Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metanephric adenoma is an extremely rare renal neoplasm, especially in pediatrics. Chemotherapy combined with surgery in metanephric adenoma has not been reported. Methods: We describe a case of metanephric adenoma in a child less than 2 years old, which were treated by chemotherapy combined with surgery. Results: Nephron sparing surgery was performed after regular chemotherapy, and the pathological result was metanephric adenoma. Conclusion: Pediatric metanephric adenoma is extremely rare; the clinical manifestations and imaging examinations lack specificity. Nephron sparing surgery is recommended as the preferred treatment for metanephric adenoma. Long-term follow-up and more in-depth molecular genetic research are still needed to determine the benign or malignant of metanephric adenoma and whether chemotherapy drugs have an effect on it.

Indexed as

chemotherapeuticschildrenmetanephric adenomanephron sparing surgeryoperation treatment

Identifiers

PMID35463907
PMCPMC9021427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.